EaseJect
EaseJect is a company established in Budapest, Hungary in December 2024.
The purpose of EaseJect’s establishment is to develop and strengthen microneedle pharmaceutical technology in Europe while fostering partnerships and advancing collaborative technology development with European stakeholders.
Introduction
Our company offers a new paradigm in drug delivery using microneedle technology.
This technology consists of patches that use microneedles, thinner than a hair, to deliver medication into the skin, providing a significant competitive advantage over traditional oral or injection methods. It is particularly important to note that we use biocompatible materials, allowing the needles to naturally dissolve once they penetrate the skin, ensuring high compatibility with the human body while also minimizing environmental impact.
Our technology is non-invasive and almost completely painless, significantly enhancing patient comfort.
By delivering the medication directly, it results in a rapid effect, while precise dosage control can also be achieved. As a result, we offer an effective and safe solution for the treatment of chronic diseases and vaccine administration. We remain committed to developing innovative products based on microneedle technology to contribute to the advancement of the medical and healthcare industries.
Our company has implemented
A system that covers the entire process of microneedle manufacturing, from the selection of biocompatible materials to design, production, quality control, and final packaging. This ensures maximum reliability and effectiveness of the microneedle technology.
Currently, we are conducting research and development activities that combine microneedles with vaccines, biosimilars, and specific drugs.
The goal of this research is to enhance the efficiency of drug delivery and provide personalized therapeutic solutions for the treatment of various diseases. We remain committed to innovation, aiming to provide even higher-quality healthcare technologies and products.
Our company has established a research laboratory in Budapest, Hungary, for the development of microneedle-based drugs.
This laboratory is specifically focused on research and development of microneedle-based medicines, and our goal is to take a leading role in the global healthcare market with innovative drug delivery technologies. Our Budapest research center, with its state-of-the-art facilities and expert team, supports the development of vaccines, biosimilars, and specialized drugs, accelerating the creation of more effective and safer therapeutic solutions.